We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GENERICS WAITING FOR BIAXIN PATENT EXPIRY; LAUNCH DATE UNCERTAIN
GENERICS WAITING FOR BIAXIN PATENT EXPIRY; LAUNCH DATE UNCERTAIN
June 29, 2004
Generic firms are in position to launch versions of Abbott Laboratories’ profitable antibiotic Biaxin once the basic patent expires next May, but expected legal moves by Abbott could delay generic entry, experts say.